| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-07 |
| mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-07 |
| mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
5e-07 |
| mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-06 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-06 |
| mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-06 |
| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
7e-06 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-06 |
| mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |